Each year on February 4, communities come together for World Cancer Day.
This year the theme is “I am and I will” and a range of HMRI-affiliated researchers have shared who they are, and what they are doing to contribute to cancer research.
Researchers in the HMRI Cancer Research Program use multidisciplinary, collaborative techniques to study many different cancers. Teams are working to develop early diagnostics, better treatments and modes of patient care to ensure the best possible outcomes for people living with cancer – and their families. There is also a broad range of researchers working toward cancer prevention strategies such as smoking cessation, nutrition and lifestyle interventions.
In partnership with the University of Newcastle’s Priority Research Centre for Cancer Research, the Hunter Cancer Research Alliance and the Calvary Mater and Hunter New England Health District, our researchers are tackling some of cancer’s greatest challenges. These researchers include clinicians, behavioural and implementation scientists and lab technicians who work in partnership with patient advocates locally, nationally and globally.
Hunter researchers are researching many different aspects of cancer including:
Our teams are working on a range of clinical trials, often in association with collaborations including the Australia New Zealand Breast Cancer Trials Group, Trans-Tasman Radiation Oncology Group and the Prostate Cancer Trials Group.
Researchers from the Hunter were also responsible for instigating the successful breast cancer screening program BreastScreen – which took to the roads in the mobile testing vans.
Brain cancer researchers can also access the Brain Cancer Biobank, funded by the Mark Hughes Foundation.
It’s a multi-faceted approach, from a diverse, talented team.